On March 6, 2023, Amprius Technologies, Inc. announced a change in Jonathan Bornstein's officer title from Chief Operating Officer to President of Amprius Lab, in conjunction with the Company's formation of two business units. Mr. Bornstein will continue to oversee the Company's operations at its laboratory and production facility in Fremont, California. Mr. Bornstein's biographical information and business experience has been previously reported in the section titled “Management” in the Company's prospectus filed with the Securities and Exchange Commission on December 2, 2022 relating to the Registration Statement on Form S-1 and such information is incorporated herein by reference.

Mr. Bornstein's compensation will not change in connection with his appointment as the President of Amprius Lab.